selected publications
- The interplay between the DNA damage response and ectonucleotidases modulates tumor response to therapy. Science immunology. 2023 Review GET IT
-
Radiation therapy improves CAR T cell activity in acute lymphoblastic leukemia.
Cell death & disease.
2023
Academic Article
GET IT
Times cited: 6 - MRI-LINAC: A transformative technology in radiation oncology. Frontiers in oncology. 2023 Review GET IT
-
Rapid, robust, and sustainable antibody responses to mRNA COVID-19 vaccine in convalescent COVID-19 individuals.
JCI insight.
2021
Academic Article
GET IT
Times cited: 16 -
Antibody Responses to SARS-CoV-2 mRNA Vaccines Are Detectable in Saliva.
Pathogens & immunity.
2021
Academic Article
GET IT
Times cited: 80 - Redistributing Central Target Dose Hot Spots for Hypofractionated Radiosurgery of Large Brain Tumors: A Proof-of-Principle Study. Acta neurochirurgica. Supplement. 2021 Academic Article GET IT
-
Radiation Therapy and the In Situ Vaccination Approach.
International journal of radiation oncology, biology, physics.
2020
Information Resource
GET IT
Times cited: 10 -
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death.
Journal for immunotherapy of cancer.
2020
Information Resource
GET IT
Times cited: 614 -
Preoperative Dural Contact and Recurrence Risk After Surgical Cavity Stereotactic Radiosurgery for Brain Metastases: New Evidence in Support of Consensus Guidelines.
Advances in radiation oncology.
2019
Academic Article
GET IT
Times cited: 14 -
Radiotherapy induces responses of lung cancer to CTLA-4 blockade.
Nature medicine.
2018
Academic Article
GET IT
Times cited: 601 -
Results of a phase I-II study of adjuvant concurrent carboplatin and accelerated radiotherapy for triple negative breast cancer.
Oncoimmunology.
2016
Academic Article
GET IT
Times cited: 9 -
Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects.
Immunity.
2016
Academic Article
GET IT
Times cited: 279 -
Use, complications, and costs of stereotactic body radiotherapy for localized prostate cancer.
Cancer.
2016
Academic Article
GET IT
Times cited: 66 -
Role of Local Radiation Therapy in Cancer Immunotherapy.
JAMA oncology.
2015
Information Resource
GET IT
Times cited: 341 -
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota.
Science (New York, N.Y.).
2015
Academic Article
GET IT
Times cited: 2387 -
Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial.
The Lancet. Oncology.
2015
Academic Article
GET IT
Times cited: 373 -
Radiotherapy for extensive stage small-cell lung cancer.
Lancet (London, England).
2015
Article
GET IT
Times cited: 1 -
Effects of convection-enhanced delivery of bevacizumab on survival of glioma-bearing animals.
Neurosurgical focus.
2015
Academic Article
GET IT
Times cited: 16 -
Quinoline-based antimalarial drugs: a novel class of autophagy inhibitors.
Neurosurgical focus.
2015
Academic Article
GET IT
Times cited: 122 -
Radiation therapy and immunotherapy: growing pains.
International journal of radiation oncology, biology, physics.
2015
Editorial Article
GET IT
Times cited: 22 -
Radiotherapy and immunogenic cell death.
Seminars in radiation oncology.
2015
Review
GET IT
Times cited: 291 -
Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy.
Neurosurgical focus.
2014
Academic Article
GET IT
Times cited: 120 -
Taxanes as radiosensitizers.
Anti-cancer drugs.
2014
Information Resource
GET IT
Times cited: 13 - Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death. Oncoimmunology. 2014 Academic Article GET IT
- Is tumor (R)ejection by the immune system the "5th R" of radiobiology?. Oncoimmunology. 2014 Academic Article GET IT
-
Inhibition of autophagy and induction of breast cancer cell death by mefloquine, an antimalarial agent.
Cancer letters.
2012
Academic Article
GET IT
Times cited: 90 -
Preferential killing of triple-negative breast cancer cells in vitro and in vivo when pharmacological aggravators of endoplasmic reticulum stress are combined with autophagy inhibitors.
Cancer letters.
2012
Academic Article
GET IT
Times cited: 48 -
Green tea epigallocatechin gallate enhances therapeutic efficacy of temozolomide in orthotopic mouse glioblastoma models.
Cancer letters.
2011
Academic Article
GET IT
Times cited: 92 -
Antiangiogenic activities of 2,5-dimethyl-celecoxib on the tumor vasculature.
Molecular cancer therapeutics.
2010
Academic Article
GET IT
Times cited: 24 -
Glioma-associated endothelial cells are chemoresistant to temozolomide.
Journal of neuro-oncology.
2009
Academic Article
GET IT
Times cited: 42 -
Enhanced killing of chemo-resistant breast cancer cells via controlled aggravation of ER stress.
Cancer letters.
2009
Academic Article
GET IT
Times cited: 42 -
Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors.
Blood.
2009
Academic Article
GET IT
Times cited: 240 -
Aggravated endoplasmic reticulum stress as a basis for enhanced glioblastoma cell killing by bortezomib in combination with celecoxib or its non-coxib analogue, 2,5-dimethyl-celecoxib.
Cancer research.
2008
Academic Article
GET IT
Times cited: 115